Ledger.Open graph →
SEC Form D · filed September 16, 2021

Lycia Therapeutics, Inc

Offering
$70.1M
Sold
$70.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
South San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

William Rieflin · New York, NYDirectorClare Ozawa · SAN DIEGO, CADirectorThomas Woiwode · Menlo Park, CADirectorAetna Wun Trombley · South San Francisco, CAExec · DirectorLaurent Fischer · Princeton, NJDirectorTim Anderson · South San Francisco, CADirectorLaurent Fischer · South San Francisco, CADirectorWilliam Rieflin · New York, NYDirectorClare Ozawa · SAN DIEGO, CADirectorThomas Woiwode · Menlo Park, CADirectorTim Anderson · South San Francisco, CADirectorAetna Wun Trombley · South San Francisco, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗